About

About

Our History

What We Do

Executive Leadership Team

Careers

Brands

Brands

Primerdesign

Yourgene Health

Southern Cross Diagnostics

Investors

Investors

RNS

Share Price

Investor Presentations

Financial Reports

Corporate Calendar

Advisors

Investor Relations

Corporate Governance

General Meetings

Board of Directors

AIM Rule 26 Information

Other Regulated Information

- Share Price
- Change

News

English

English
French

Information sur les résultats du 1er semestre 2026

Home | Investors | RNS | Information sur les résultats du 1er semestre 2026

Download as a PDF

Return to RNS Feed

Novacyt is an international molecular diagnostics company providing a broad portfolio of integrated technologies and services, primarily focused on the delivery of genomic medicine.

Navigation

Home
Investors
About
News
Policies
Contact

Company Information

Skelton House, Lloyd Street North, Manchester Science Park, Manchester, M15 6SH

Novacyt UK Holdings - 12031776
Novacyt SA - 491062527

© 2026 Novacyt | Privacy Policy | Copyright | Terms & Conditions | Sitemap | Website by: Stacksmiths